pioglitazone has been researched along with Essential Tremor in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Essential Tremor: A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aghaei, I | 1 |
Hajali, V | 1 |
Haghani, M | 1 |
Vaziri, Z | 1 |
Moosazadeh, M | 1 |
Shabani, M | 1 |
1 other study available for pioglitazone and Essential Tremor
Article | Year |
---|---|
Peroxisome proliferator-activated receptor-γ activation attenuates harmaline-induced cognitive impairments in rats.
Topics: Animals; Behavior, Animal; Cognitive Dysfunction; Essential Tremor; Harmaline; Male; Maze Learning; | 2019 |